Join the club for FREE to access the whole archive and other member benefits.

Personalised breast cancer programme launches in Cambridge

18-Nov-2016

Key points from article :

Cancer Research UK Cambridge Institute’s programme will map patients’ DNA and RNA to tailor treatment to individuals.

Will analyse the genome and all expressed genes of tumour cells from 250 breast cancer patients.

There are around 10 different types of breast cancer and these respond differently to the available treatments.

“We’re looking at ways to predict this response ensuring individual patients get the best treatment for them.” – Sir Harpal Kumar

Mentioned in this article:

Click on resource name for more details.

Cancer Research UK Cambridge Institute (CRUK)

Cancer research centre in the UK.

Harpal Kumar

Head of Johnson & Johnson Innovation, EMEA at Johnson & Johnson.

Richard Gilbertson

Director of Cancer Centre at University of Cambridge.

Topics mentioned on this page:
Cancer